Clinical Trial

Effect Of Health Extension Worker-Led Based Interventions on Improving Self-Management Behavior Among Diabetic Patients in Ethiopia

Study acronym: HEWL-SMB
Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated August 9, 2024 (before its estimated February 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
Despite the existence of lifestyle interventions designed to encourage self-management behaviors, the difficulty of adhering to recommended practices remains a widespread issue globally, including in Ethiopia. Traditional approaches to care have demonstrated limited effectiveness in promoting self-management behavior. As a potential solution, a Health Extension Worker-Led club-based intervention has been implemented. Therefore, the aim of this study is to assess the impact of the Health Extension Worker-Led club-based intervention on improving self-management behaviors and glycemic control. The study will utilize a parallel-group, cluster randomized controlled trial design to investigate its objectives. The main focus of the research is to assess the average increase, both in terms of mean and percentage, in adherence to self-management behaviors and glycemic control. Additionally, the study aims to evaluating the acceptance of the intervention. To evaluate the impact of a Health Extension Worker-led intervention on self-management behavior and levels of glycosylated hemoglobin (HbA1C), a difference-in-difference analysis will be employed. A comparison of the intervention's effects across different groups will be conducted using an independent-sample t-test.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-12-19.
Status change: Not Yet Recruiting → Enrolling by Invitation 2024-08-06
Trial Details
NCT Number NCT06189417
Lead Sponsor Debre Berhan University
Collaborators: University of South Africa
Conditions Diabetes Mellitus, Self-management Behavior and Glycosylated Hemoglobin Levels
Enrollment 560 participants
Start Date 2024-02-01
Primary Completion 2025-02-01 (estimated)
Study Completion 2025-02-01 (estimated)
Updated on ClinicalTrials.gov 2024-08-09